Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03162796
Brief Title: A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) (Discover-1)

First Submitted : May 19, 2017
First Submitted that Met QC Criteria : May 19, 2017
First Posted : May 22, 2017

Certification/Extension First Submitted : March 13, 2020
Certification/Extension First Submitted that Met QC Criteria : March 13, 2020
Certification/Extension First Posted : March 16, 2020

Last Update Submitted that Met QC Criteria : March 13, 2020
Last Update Posted : March 16, 2020